Simplex Trading
NERV icon

Simplex Trading’s Minerva Neurosciences NERV Stock Holding History

Simplex Trading’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,500
Closed -$8K – 10548
2022
Q2 		$8K Buy
2,500
+1,987
+387% +$8.12K ﹤0.01% 8484
2022
Q1 		$3K Sell
513
-1,725
-77% -$10.6K ﹤0.01% 9722
2021
Q4 		$14K Sell
2,238
-137
-6% -$1.29K ﹤0.01% 8754
2021
Q3 		$44K Hold
2,375
– – ﹤0.01% 7661
2021
Q2 		$44K Buy
2,375
+2,370
+47,400% +$51K ﹤0.01% 7802
2021
Q1 		$10K Buy
+5
New +$125 ﹤0.01% 7891
2020
Q2 		– Sell
-214
Closed -$1.03M – 8083
2020
Q1 		$1.03M Buy
214
+178
+494% +$10.7K ﹤0.01% 1856
2019
Q4 		$203K Buy
36
+17
+89% +$750 ﹤0.01% 3742
2019
Q3 		$115K Buy
+19
New +$1.08K ﹤0.01% 4169
2019
Q1 		– Sell
-2
Closed -$9K – 7604
2018
Q4 		$9K Hold
2
– – ﹤0.01% 5907
2018
Q3 		$17K Hold
2
– – ﹤0.01% 6083
2018
Q2 		$13K Buy
+2
New +$121 ﹤0.01% 6172
2016
Q4 		– Sell
-17
Closed -$97K – 6289
2016
Q3 		$97K Buy
+17
New +$1.65K 0.01% 1552

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Simplex Trading's NERV Position: Q3 2022 in Review

Simplex Trading sold out of Minerva Neurosciences (NERV) in Q3 2022, closing a stake of 251 shares.

Simplex Trading first reported a position in NERV in Q2 2017 and held it in 13 quarters. The position peaked at $382K in Q1 2020. 25 funds tracked by Wall St. Rank hold NERV as of Q3 2022.

  • Simplex Trading reported no remaining Minerva Neurosciences position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 251 Minerva Neurosciences shares in Q3 2022.
  • Simplex Trading first reported a position in Minerva Neurosciences in Q2 2017 and held it in 13 quarters.
  • Simplex Trading's Minerva Neurosciences position peaked at $382K in Q1 2020.
  • 25 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.